Trial Profile
Effects of azilsartan compared to other angiotensin receptor blockers on left ventricular hypertrophy and the sympathetic nervous system in hemodialysis patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 May 2016
Price :
$35
*
At a glance
- Drugs Azilsartan (Primary) ; Angiotensin receptor antagonists
- Indications Hypertension
- Focus Pharmacodynamics; Therapeutic Use
- 07 Oct 2013 New trial record